Investors / United States / Alix Ventures
Alix Ventures
Venture capital · San Francisco, CA, United States · North America
Alix Ventures is a venture capital firm that supports early stage life science startups engineering biology. It provides capital, a platform of resources for customer introductions, fundraising and team building, and a community and content platform called BIOS.
Invests inHealthcare & Biotech
In its own wordslife sciencestechbiobiotechtherapeuticsdiagnosticsbio-economy infrastructure
Your fit with Alix Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAlix Ventures lists 17 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (84%), AI & Machine Learning (5%) and Space & Defense (5%). 92% of its companies are based in United States. It invests most often alongside KdT Ventures, BlueYard Capital and 8VC.
Counts come from funding rounds that name Alix Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Alix Ventures' whole history. Rounds on record name 2 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 50% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 1 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 66th | 6% of companies confirmed by a round |
| Sector focus | 94th | 84% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| KdT Ventures | 4 |
| BlueYard Capital | 3 |
| 8VC | 2 |
| Creative Destruction Lab | 2 |
| DCVC | 2 |
| Future Ventures | 2 |
| Possible Ventures | 2 |
| Triatomic Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers17100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 84% | 15% |
| AI & Machine Learning | 5% | 18% |
| Space & Defense | 5% | 3% |
| Robotics & Hardware | 5% | 1% |
Co-investor network
who it backs companies with, and who they back togetherCompare Alix Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Alix Ventures| Date | Company | Stage |
|---|---|---|
| 29 Oct 2025 | Seed | |
| 1 Dec 2021 | Series A |
Round details for Alix Ventures
Amounts, full round histories and every co-investor in Alix Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops a platform and products for advanced therapeutics, including gene therapies, cell therapies, and biologics. | Healthcare & Biotech | Portfolio page | ||
| Basil Systems provides data and insights for life sciences companies using next-generation technology and AI | Healthcare & Biotech | Portfolio page | ||
| Chemify digitizes molecule creation using chemistry, robotics, computation, machine learning and a programming language | Robotics & HardwareHealthcare & Biotech | Portfolio page | ||
| Clora operates a talent marketplace for life sciences, providing access to vetted biotech and pharma consultants | Healthcare & Biotech | Portfolio page | ||
| Cytosolix redesigns small molecule drugs to target them to tumors by exploiting a universal feature of solid tumors: acidity. | Healthcare & Biotech | Portfolio page | ||
| Elegen produces DNA using cell-free gene synthesis technology | Healthcare & Biotech | Dec 2021Series A | Page + round | |
| The company develops technologies to manage patient variability and make local production of cell therapies possible | Healthcare & Biotech | Portfolio page | ||
| Galatea Bio helps organizations design and execute projects that utilize human genetic diversity to solve problems in biomedicine | Healthcare & Biotech | Portfolio page | ||
| The company creates human cells and organoids using a precision engineering platform for in vitro modeling and cell therapies. | Healthcare & Biotech | Oct 2025Seed | Funding round | |
| Mythic develops and manufactures artificial intelligence products, including analog processing units and AI platforms, for various industries such as automotive, robotics, and enterprise. | AI & Machine LearningSpace & Defense | Portfolio page | ||
| Pair Team combines a care team with AI to coordinate care for people with Medicaid or Medicare, covering medical, behavioral, and social support. | Healthcare & Biotech | Portfolio page | ||
| Strand is a clinical-stage biotechnology company with a pipeline of breakthrough mRNA therapeutics for cancers and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| STRM.BIO is developing a platform for in vivo gene therapy delivery using megakaryocyte-derived extracellular vesicles | Healthcare & Biotech | Portfolio page | ||
| Teiko provides cytometry services for monitoring the immune response in clinical trials | Healthcare & Biotech | Portfolio page | ||
| Endpoint conducts real-world evidence studies using an AI-powered platform with patient records | Healthcare & Biotech | Portfolio page | ||
| Xilis developed micro-organosphere technology now sold by Uniform Bio as MOSgen. | Healthcare & Biotech | Portfolio page | ||
| Zafrens develops technology for high-throughput drug discovery using multi-omics and large perturbation libraries | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- alix.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 1 Dec 2021
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Alix Ventures' profile as data
Pull Alix Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/alix.vc
# also
GET /v1/firms/alix.vc/portfolio
GET /v1/firms/alix.vc/coinvestors
GET /v1/firms/alix.vc/news